Drug Type TCR-T Cell therapy |
Synonyms- |
Target |
Action modulators |
Mechanism MAGEA4 modulators(Melanoma-associated antigen 4 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Brain Cancer | Phase 1 | China | 15 Mar 2026 | |
| Locally Advanced Malignant Neoplasm | Phase 1 | China | 15 Mar 2026 | |
| Neoplasm Metastasis | Phase 1 | China | 15 Mar 2026 | |
| Osteosarcoma | Phase 1 | China | 15 Mar 2026 | |
| Phyllodes Tumor | Phase 1 | China | 15 Mar 2026 | |
| Soft Tissue Sarcoma | Phase 1 | China | 15 Mar 2026 |





